Join industry leaders in exclusive sessions with Dr. Fein, where they will engage in candid, in-depth discussions covering all aspects of the drug channel. Gain unique insights and perspectives you won't find anywhere else.
Featuring candid conversations with top leaders, innovators, and policy makers on key topics shaping the U.S. pharmaceutical ecosystem.
The inaugural Drug Channels Leadership Forum will explore the most pressing strategic issues and crucial uncertainties that will affect all participants across the U.S. drug channel. Join us for this unique opportunity to learn and share with an exclusive group of your peers from all segments of the drug channel.
March 17–19, 2025
JW Marriott Miami Turnberry Resort and Spa
Miami, Florida
Adam J. Fein is President of Drug Channels Institute (DCI), an HMP Global company. DCI helps its customers make sense of pharmaceutical economics and the increasingly complex pharmacy distribution and reimbursement system.
Dr. Fein is one of the country’s foremost experts on the pharmaceutical industry. He has published hundreds of academic and industry articles. Dr. Fein has contributed to and is regularly quoted in such national publications as the Wall Street Journal, the New York Times, Washington Post, Forbes, and many others. His popular and influential Drug Channels website is the go-to source for definitive and comprehensive industry analysis, delivered with a witty edge.
Join industry leaders in exclusive sessions with Dr. Fein, where they will engage in candid, in-depth discussions covering all aspects of the drug channel. Gain unique insights and perspectives you won't find anywhere else.
Steven H. Collis is Chairman, President, and Chief Executive Officer of Cencora, Inc. Under Steve’s leadership, the company has experienced tremendous financial growth with annual revenue tripling from $80 billion since being named CEO in 2011, as well as significant global expansion with more than 46,000 team members spread across more than 50 countries.
Frank Cunningham is group vice president of Group Vice President, Global Value and Access & Lilly Direct for Lilly USA and Eli Lilly and Company. Since joining Lilly in November 1995, Frank has dedicated most of his career to leading Global Value and Access teams, securing industry-leading patient access to the Lilly product portfolio.
David Joyner is executive vice president, CVS Health®, and president, CVS Caremark®. He leads the pharmacy services segment, which provides solutions to employers, health plans and government businesses and serves more than 110 million members through CVS Caremark, CVS Specialty® and other areas.
Prem Shah is executive vice president and chief pharmacy officer, CVS Health® and president, Pharmacy and Consumer Wellness. As chief pharmacy officer, Prem has oversight and responsibility for the company’s omnichannel pharmacy strategy focused on integration across all channels to make pharmacy interactions as personalized and seamless as possible to meet the needs of consumers when and where they want them, including at home, virtually and in the community.
Tim Wentworth joined Walgreens Boots Alliance, Inc. as Chief Executive Officer in October 2023. He also is a Director on WBA’s Board. Most recently, from September 2020 to December 2021, as founding CEO of Evernorth, Cigna’s health services organization that partners with health plans, employers and government organizations, Mr. Wentworth brought together health service capabilities including care provision, pharmacy solutions and benefits management.
Delve into the heart of industry trends and challenges with intimate fireside chats with industry thought leaders, analysts, and executives at the drug channels forefront. Dr. Fein will personally lead those fireside discussions.
Experience a dynamic and interactive environment where ideas flow freely and collaboration thrives. Our salon-style approach fosters open dialogue and a meaningful exchange of perspectives. Engage in lively discussions and debates on the most pressing issues facing pharmaceutical distribution channels.
Engage in thought-provoking conversations that explore the complexities of the rapidly evolving drug channels landscape. Delve into disruption and what’s driving success today.
Drug Channels Leadership Forum will tackle pressing topics and ask tough questions.
Connect and cultivate relationships with thought leaders and solution providers that extend beyond the forum, further driving collaboration and growth.